» Authors » Luiz Henrique C Sangenis

Luiz Henrique C Sangenis

Explore the profile of Luiz Henrique C Sangenis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 92
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de Lima A, Mendes V, Rodrigues Ferreira R, Nisimura L, Horita S, Veloso H, et al.
Mem Inst Oswaldo Cruz . 2023 Dec; 118:e230115. PMID: 38126526
Background: A positive Trypanosoma cruzi polymerase chain reaction (PCR) is associated with a worse prognosis in patients with chronic Chagas disease (CD). Objectives: To study the association of clinical, electrocardiographic,...
2.
Mediano M, Ribeiro L, Silva R, Xavier I, Vieira M, Goncalves T, et al.
Front Med (Lausanne) . 2023 Oct; 10:1292606. PMID: 37841016
[This corrects the article DOI: 10.3389/fmed.2022.1087188.].
3.
Mendes V, Rimolo L, de Lima A, Ferreira R, Oliveira L, Nisimura L, et al.
J Am Heart Assoc . 2023 Jun; 12(12):e028810. PMID: 37313975
Background Chagas disease (CD) presents an ominous prognosis. The predictive value of biomarkers and new echocardiogram parameters in adjusted models have not been well studied. Methods and Results There were...
4.
Mediano M, Ribeiro L, Silva R, Xavier I, Vieira M, Goncalves T, et al.
Front Med (Lausanne) . 2023 Jan; 9:1087188. PMID: 36687410
Background: Chagas disease (CD) is a neglected endemic disease with worldwide impact due to migration. Approximately 50-70% of individuals in the chronic phase of CD present the indeterminate form, characterized...
5.
Portela L, Mesquita M, Giraldes J, Varela M, Brasil P, Costa A, et al.
Trans R Soc Trop Med Hyg . 2022 Jul; 117(2):102-110. PMID: 35896031
Background: Chagas disease (CD) is still an important public health issue in Latin America. This study aims to analyse the association between socio-epidemiological factors and comorbidities with clinical manifestations of...
6.
Saraiva R, Mediano M, Quintana M, da Silva G, Costa A, Sousa A, et al.
Int J Cardiol Heart Vasc . 2022 Feb; 38:100955. PMID: 35169612
Background: Patients with chronic Chagas disease (CD) cardiomyopathy have a high mortality. We evaluated if two-dimensional (2D) strain () parameters provide independent predictors of progression to CD cardiomyopathy and all-cause...
7.
Saraiva R, Mediano M, Mendes F, da Silva G, Veloso H, Sangenis L, et al.
World J Cardiol . 2022 Jan; 13(12):654-675. PMID: 35070110
Chagas heart disease (CHD) affects approximately 30% of patients chronically infected with the protozoa . CHD is classified into four stages of increasing severity according to electrocardiographic, echocardiographic, and clinical...
8.
Holanda M, Mediano M, Hasslocher-Moreno A, Gonzaga B, Carvalho A, Ferreira R, et al.
EClinicalMedicine . 2021 Sep; 40:101105. PMID: 34485877
Background: Chagas disease (caused by infection) evolves to chronic chagasic cardiomyopathy (CCC) affecting 1.8 million people worldwide. This is the first randomized, placebo-controlled, double-blinded, clinical trial designed to estimate efficacy...
9.
Saraiva R, Pacheco N, Pereira T, Costa A, Holanda M, Sangenis L, et al.
J Am Soc Echocardiogr . 2020 Aug; 33(11):1363-1374.e1. PMID: 32747223
Background: Atrial fibrillation (AF) carries ominous consequences in patients with Chagas disease. The aim of this study was to determine whether left atrial (LA) volume and function assessed using three-dimensional...
10.
Curvo E, Ferreira R, Madeira F, Alves G, Chambela M, Mendes V, et al.
Mem Inst Oswaldo Cruz . 2018 Mar; 113(4):e170440. PMID: 29513876
Background: Transforming growth factor β1 (TGF-β1) and tumour necrosis factor (TNF) have been implicated in Chagas disease pathophysiology and may correlate with left ventricular (LV) function. Objectives: We determined whether...